Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel covalent and non-covalent complex-based pharmacophore models of SARS-CoV-2 main protease (Mpro) elucidated by microsecond MD simulations
Yasser Hayek-Orduz, Andrés Felipe Vásquez, Maria F. Villegas-Torres, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 15

Showing 15 citing articles:

Prediction of Binding Pose and Affinity of Nelfinavir, a SARS-CoV-2 Main Protease Repositioned Drug, by Combining Docking, Molecular Dynamics, and Fragment Molecular Orbital Calculations
Yuma Handa, Koji Okuwaki, Yusuke Kawashima, et al.
The Journal of Physical Chemistry B (2024) Vol. 128, Iss. 10, pp. 2249-2265
Open Access | Times Cited: 10
Computer-aided drug design of novel nirmatrelvir analogs inhibiting main protease of Coronavirus SARS-CoV-2
Kateryna Lohachova, Anastasiia S . Sviatenko, Alexander Kyrychenko, et al.
Journal of Applied Pharmaceutical Science (2024)
Open Access | Times Cited: 5
CHARMM-GUI PDB Reader and Manipulator: Covalent Ligand Modeling and Simulation
Lingyang Kong, Sang‐Jun Park, Wonpil Im
Journal of Molecular Biology (2024) Vol. 436, Iss. 17, pp. 168554-168554
Closed Access | Times Cited: 2
Pharmacophore Virtual Screening Identifies Riboflavin as an Inhibitor of the Schistosome Cathepsin B1 Protease with Antiparasitic Activity
Ramon M. Cogo, Thais Fernanda Amorim Pavani, Ana C. Mengarda, et al.
ACS Omega (2024) Vol. 9, Iss. 23, pp. 25356-25369
Open Access | Times Cited: 2
Main and papain-like proteases as prospective targets for pharmacological treatment of coronavirus SARS-CoV-2
Larysa V. Yevsieieva, Kateryna Lohachova, Alexander Kyrychenko, et al.
RSC Advances (2023) Vol. 13, Iss. 50, pp. 35500-35524
Open Access | Times Cited: 7
Pharmacophore Oriented MP2 Characterization of Charge Distribution for Anti-SARS-CoV-2 Inhibitor Nirmatrelvir
Yuemin Liu, Rulong Ma, Hua‐Jun Fan, et al.
Journal of Molecular Structure (2023) Vol. 1290, pp. 135871-135871
Open Access | Times Cited: 5
Lead compound discovery using pharmacophore-based models of small-molecule metabolites from human blood as inhibitor cellular entry of SARS-CoV-2
Ellin Febrina, Aiyi Asnawi
Journal of Pharmacy & Pharmacognosy Research (2023) Vol. 11, Iss. 5, pp. 810-822
Open Access | Times Cited: 5
The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study
Mateus Sá Magalhães Serafim, Simone Queiroz Pantaleão, Elany Barbosa da Silva, et al.
Frontiers in Drug Discovery (2023) Vol. 3
Open Access | Times Cited: 4
Microsecond Simulation in a Special-Purpose Molecular Dynamics Computer Cluster
Nan Sheng, Zhengqing Tong, Chengqian Jiang, et al.
(2023), pp. 151-157
Closed Access | Times Cited: 2
Taming the storm: potential anti-inflammatory compounds targeting SARS-CoV-2 MPro
Débora Bublitz Anton, Jeferson Camargo de Lima, Bruno Rampanelli Dahmer, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 3007-3035
Closed Access
Cardioprotective effects of cinnamoyl imidazole on apoptosis and oxidative stress in hypoxia/reoxygenation-induced H9C2 cell lines
Sreya Kosanam, Rajeshwari Pasupula
Life Sciences (2024), pp. 123189-123189
Closed Access
Consensus Pharmacophore Strategy For Identifying Novel SARS-Cov-2 Mpro Inhibitors from Large Chemical Libraries
Angel J. Ruiz‐Moreno, Raziel Cedillo-González, Luis Córdova-Bahena, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 6, pp. 1984-1995
Open Access
A Structural Investigation of the Interaction between a GC-376-Based Peptidomimetic PROTAC and Its Precursor with the Viral Main Protease of Coxsackievirus B3
Alessia De Santis, Deborah Grifagni, A Orsetti, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1260-1260
Open Access
Discovery of Natural Compounds as SARS-CoV-2’s Main Protease Inhibitors by Docking-based Virtual Screening
Jing Wang, Yu Jiang, Yingnan Wu, et al.
Letters in Drug Design & Discovery (2023) Vol. 21, Iss. 10, pp. 1604-1610
Closed Access
Tetrandrine, an Effective Inhibitor of COVID-19 Main Protease (Mpro); Insights from Molecular Docking and Dynamics Simulations
Arifa Begum SK, Shaheen Begum, Pranay Bandari, et al.
International Journal of Pharmaceutical Investigation (2023) Vol. 13, Iss. 4, pp. 845-851
Open Access
Page 1

Scroll to top